In a study involving four cancer cell lines, ovarian and an inherently cisplatin-resistant colon (HT-29), ERCC1 mRNA levels measured after exposure to oxaliplatin for 20 hours were higher than in the control—the A2780 (ovarian) cell line [8]. This evidence concerns the gene ERCC1 and cancer.